TDACW
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Financial - Conglomerates · US
$1.15
−3.36%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.09
From 52W high−46.51%
Volume2702.00
Market cap$19.84M
P/E (TTM)4.5x
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$1.09
From 52W high
−46.51%
Volume
2702.00
Market cap
$19.84M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−15.8x
P/E (TTM)
4.5x
RSI (14)
38.8
MomentumView details →
1D Return
−3.36%
YTD Return
+238.71%
Similar companies
Cartesian Growth Corporation IIIFACWWBRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred StockRILYPBayview Acquisition Corp UnitBAYAUJones Ventures INTL Acquisition1 Corp RightsJONERKarbon Capital Partners Corp.KBONWBRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series B Cumulative Perpetual Preferred StockRILYLFind similar companies →
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.99d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.121d ago